181 related articles for article (PubMed ID: 38390756)
1. Targeting KDM4 family epigenetically triggers antitumour immunity via enhancing tumour-intrinsic innate sensing and immunogenicity.
Sun M; Han X; Li J; Zheng J; Li J; Wang H; Li X
Clin Transl Med; 2024 Feb; 14(2):e1598. PubMed ID: 38390756
[TBL] [Abstract][Full Text] [Related]
2. Caspase-9 inhibition triggers Hsp90-based chemotherapy-mediated tumor intrinsic innate sensing and enhances antitumor immunity.
Li J; Han X; Sun M; Li W; Yang G; Chen H; Guo B; Li J; Li X; Wang H
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38056894
[TBL] [Abstract][Full Text] [Related]
3. DNA sensing in cancer: Pro-tumour and anti-tumour functions of cGAS-STING signalling.
Wheeler OPG; Unterholzner L
Essays Biochem; 2023 Sep; 67(6):905-918. PubMed ID: 37534795
[TBL] [Abstract][Full Text] [Related]
4. KDM5 histone demethylases repress immune response via suppression of STING.
Wu L; Cao J; Cai WL; Lang SM; Horton JR; Jansen DJ; Liu ZZ; Chen JF; Zhang M; Mott BT; Pohida K; Rai G; Kales SC; Henderson MJ; Hu X; Jadhav A; Maloney DJ; Simeonov A; Zhu S; Iwasaki A; Hall MD; Cheng X; Shadel GS; Yan Q
PLoS Biol; 2018 Aug; 16(8):e2006134. PubMed ID: 30080846
[TBL] [Abstract][Full Text] [Related]
5. A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth.
Wang L; Chang J; Varghese D; Dellinger M; Kumar S; Best AM; Ruiz J; Bruick R; Peña-Llopis S; Xu J; Babinski DJ; Frantz DE; Brekken RA; Quinn AM; Simeonov A; Easmon J; Martinez ED
Nat Commun; 2013; 4():2035. PubMed ID: 23792809
[TBL] [Abstract][Full Text] [Related]
6. JIB-04, a Pan-Inhibitor of Histone Demethylases, Targets Histone-Lysine-Demethylase-Dependent AKT Pathway, Leading to Cell Cycle Arrest and Inhibition of Cancer Stem-Like Cell Properties in Hepatocellular Carcinoma Cells.
Lee J; Kim JS; Cho HI; Jo SR; Jang YK
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887001
[TBL] [Abstract][Full Text] [Related]
7. Targeting KDM4A epigenetically activates tumor-cell-intrinsic immunity by inducing DNA replication stress.
Zhang W; Liu W; Jia L; Chen D; Chang I; Lake M; Bentolila LA; Wang CY
Mol Cell; 2021 May; 81(10):2148-2165.e9. PubMed ID: 33743195
[TBL] [Abstract][Full Text] [Related]
8. Advances in histone demethylase KDM4 as cancer therapeutic targets.
Lee DH; Kim GW; Jeon YH; Yoo J; Lee SW; Kwon SH
FASEB J; 2020 Mar; 34(3):3461-3484. PubMed ID: 31961018
[TBL] [Abstract][Full Text] [Related]
9. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation.
Du SS; Chen GW; Yang P; Chen YX; Hu Y; Zhao QQ; Zhang Y; Liu R; Zheng DX; Zhou J; Fan J; Zeng ZC
Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1243-1255. PubMed ID: 34986380
[TBL] [Abstract][Full Text] [Related]
10. KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells.
Berry WL; Janknecht R
Cancer Res; 2013 May; 73(10):2936-42. PubMed ID: 23644528
[TBL] [Abstract][Full Text] [Related]
11. KDM4 Demethylases: Structure, Function, and Inhibitors.
Jiang Y; Liu L; Yang ZQ
Adv Exp Med Biol; 2023; 1433():87-111. PubMed ID: 37751137
[TBL] [Abstract][Full Text] [Related]
12. TACH101, a first-in-class pan-inhibitor of KDM4 histone demethylase.
Chandhasin C; Dang V; Perabo F; Del Rosario J; Chen YK; Filvaroff E; Stafford JA; Clarke M
Anticancer Drugs; 2023 Nov; 34(10):1122-1131. PubMed ID: 37067993
[TBL] [Abstract][Full Text] [Related]
13. The paradoxical role of radiation-induced cGAS-STING signalling network in tumour immunity.
Zhang X; Zhang H; Zhang J; Yang M; Zhu M; Yin Y; Fan X; Yu F
Immunology; 2023 Mar; 168(3):375-388. PubMed ID: 36217274
[TBL] [Abstract][Full Text] [Related]
14. KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.
Chin YW; Han SY
Expert Opin Ther Pat; 2015 Feb; 25(2):135-44. PubMed ID: 25468267
[TBL] [Abstract][Full Text] [Related]
15. KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements.
Zhang SM; Cai WL; Liu X; Thakral D; Luo J; Chan LH; McGeary MK; Song E; Blenman KRM; Micevic G; Jessel S; Zhang Y; Yin M; Booth CJ; Jilaveanu LB; Damsky W; Sznol M; Kluger HM; Iwasaki A; Bosenberg MW; Yan Q
Nature; 2021 Oct; 598(7882):682-687. PubMed ID: 34671158
[TBL] [Abstract][Full Text] [Related]
16. Harnessing stemness and PD-L1 expression by AT-rich interaction domain-containing protein 3B in colorectal cancer.
Liao TT; Lin CC; Jiang JK; Yang SH; Teng HW; Yang MH
Theranostics; 2020; 10(14):6095-6112. PubMed ID: 32483441
[No Abstract] [Full Text] [Related]
17. Ponatinib delays the growth of solid tumours by remodelling immunosuppressive tumour microenvironment through the inhibition of induced PD-L1 expression.
Barnwal A; Tamang R; Sanjeev Das ; Bhattacharyya J
Br J Cancer; 2023 Oct; 129(6):1007-1021. PubMed ID: 37400678
[TBL] [Abstract][Full Text] [Related]
18. Duck Enteritis Virus Inhibits the cGAS-STING DNA-Sensing Pathway To Evade the Innate Immune Response.
Gao L; Liu R; Yang F; Li X; Liu C; Qi X; Cui H; Zhang Y; Wang S; Wang X; Gao Y; Li K
J Virol; 2022 Dec; 96(24):e0157822. PubMed ID: 36448809
[TBL] [Abstract][Full Text] [Related]
19. JIB-04, a histone demethylase Jumonji C domain inhibitor, regulates phenotypic switching of vascular smooth muscle cells.
He Y; Yi X; Zhang Z; Luo H; Li R; Feng X; Fang ZM; Zhu XH; Cheng W; Jiang DS; Zhao F; Wei X
Clin Epigenetics; 2022 Aug; 14(1):101. PubMed ID: 35964071
[TBL] [Abstract][Full Text] [Related]
20. Ataxia telangiectasia mutated kinase inhibition promotes irradiation-induced PD-L1 expression in tumour-associated macrophages through IFN-I/JAK signalling pathway.
Gao Y; Li Y; Lin Z; Zeng Y; Huang Z; Han L; Zhong Y; Gong Y; Wu Q; Xie C
Immunology; 2023 Feb; 168(2):346-361. PubMed ID: 36326481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
